Show simple item record

 
dc.contributorHospital Universitari de Girona Dr Josep Trueta
dc.contributor.authorPolonio-Alcalá, Emma
dc.contributor.authorRabionet Diaz, Marc
dc.contributor.authorRuiz-Martínez, Santiago
dc.contributor.authorPalomeras Pairet, Sònia
dc.contributor.authorPORTA, RUT
dc.contributor.authorVasquez-Dongo, Carmen Amalia
dc.contributor.authorPuig, Teresa
dc.contributor.authorCiurana, Joaquim
dc.contributor.authorBosch-Barrera, Joaquim
dc.date.accessioned2024-04-02T10:10:57Z
dc.date.available2024-04-02T10:10:57Z
dc.date.issued2021-10-22
dc.identifier.citationPolonio-Alcalá E, Rabionet M, Ruiz-Martinez S, Palomeras S, Porta R, Vásquez-Dongo C, et al. Polycaprolactone Electrospun Scaffolds Produce an Enrichment of Lung Cancer Stem Cells in Sensitive and Resistant EGFRm Lung Adenocarcinoma. Cancers (Basel). 2021 Oct 22;13(21):5320.
dc.identifier.urihttps://hdl.handle.net/11351/11265
dc.descriptionThree Dimensional Cell Culture; Stem Cell; Lung neoplasm
dc.description.abstractThe establishment of a three-dimensional (3D) cell culture model for lung cancer stem cells (LCSCs) is needed because the study of these stem cells is unable to be done using flat surfaces. The study of LCSCs is fundamental due to their key role in drug resistance, tumor recurrence, and metastasis. Hence, the purpose of this work is the evaluation of polycaprolactone electrospun (PCL-ES) scaffolds for culturing LCSCs in sensitive and resistant EGFR-mutated (EGFRm) lung adenocarcinoma cell models. We performed a thermal, physical, and biological characterization of 10% and 15%-PCL-ES structures. Several genes and proteins associated with LCSC features were analyzed by RT-qPCR and Western blot. Vimentin and CD133 tumor expression were evaluated in samples from 36 patients with EGFRm non-small cell lung cancer through immunohistochemistry. Our findings revealed that PC9 and PC9-GR3 models cultured on PCL-ES scaffolds showed higher resistance to osimertinib, upregulation of ABCB1, Vimentin, Snail, Twist, Sox2, Oct-4, and CD166, downregulation of E-cadherin and CD133, and the activation of Hedgehog pathway. Additionally, we determined that the non-expression of CD133 was significantly associated with a low degree of histological differentiation, disease progression, and distant metastasis. To sum up, we confirmed PCL-ES scaffolds as a suitable 3D cell culture model for the study of the LCSC niche.
dc.language.isoeng
dc.publisherMDPI
dc.relation.ispartofseriesCancers;13(21)
dc.rightsAttribution 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.sourceScientia
dc.subjectCèl·lules mare
dc.subjectPulmons--Càncer
dc.subjectPulmons - Càncer
dc.subject.meshNeoplastic Stem Cells
dc.subject.meshCell Culture Techniques
dc.subject.meshLung Neoplasms
dc.titlePolycaprolactone Electrospun Scaffolds Produce an Enrichment of Lung Cancer Stem Cells in Sensitive and Resistant EGFRm Lung Adenocarcinoma
dc.typeinfo:eu-repo/semantics/article
dc.identifier.doi10.3390/cancers13215320
dc.subject.decstécnicas de cultivo celular
dc.subject.decsneoplasias pulmonares
dc.relation.publishversionhttps://doi.org/10.3390/cancers13215320
dc.audienceProfessionals
dc.contributor.organismesInstitut Català de la Salut
dc.event.productorBiblioteca
dc.contributor.authoraffiliation[Polonio-Alcalá E, Rabionet M] Product, Process and Production Engineering Research Group (GREP), Department of Mechanical Engineering and Industrial Construction, University of Girona, Girona, Spain. New Therapeutic Targets Laboratory (TargetsLab)-Oncology Unit, Department of Medical Sciences, Faculty of Medicine, University of Girona, Girona, Spain. [Ruiz-Martínez S, Palomeras S, Puig T] New Therapeutic Targets Laboratory (TargetsLab)-Oncology Unit, Department of Medical Sciences, Faculty of Medicine, University of Girona, Girona, Spain. [Porta R] New Therapeutic Targets Laboratory (TargetsLab)-Oncology Unit, Department of Medical Sciences, Faculty of Medicine, University of Girona, Girona, Spain. Medical Oncology Department, Catalan Institute of Oncology, Girona, Spain. [Vásquez-Dongo C] New Therapeutic Targets Laboratory (TargetsLab)-Oncology Unit, Department of Medical Sciences, Faculty of Medicine, University of Girona, Girona, Spain. Department of Pathology, Hospital Universitari de Girona Doctor Josep Trueta, Institut Català de la Salut (ICS), Girona, Spain. [Bosch-Barrera J] Medical Oncology Department, Catalan Institute of Oncology, Girona, Spain. [ Ciurana J] Product, Process and Production Engineering Research Group (GREP), Department of Mechanical Engineering and Industrial Construction, University of Girona, Girona, Spain
dc.identifier.pmid34771484
dc.rights.accessrightsinfo:eu-repo/semantics/openAccess


Files in this item

Thumbnail
Thumbnail
Thumbnail
Thumbnail
Thumbnail
Thumbnail
Thumbnail
Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record